Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria

Precise evaluation of the efficacy of immunotherapy is critical in the effective management and treatment of advanced hepatocellular carcinoma (HCC). Therefore, the purpose of this study was to compare the response assessments achieved by different criteria and to evaluate the correlation between su...

Celý popis

Podrobná bibliografie

Vydáno v:	Frontiers in oncology Ročník 11; s. 764189
Hlavní autoři:	Zhou, Meng, Zhang, Chunhui, Nie, Jianhua, Sun, Yajuan, Xu, Ye, Wu, Fangfang, Huang, Yuhong, Li, Shun, Wang, Yuan, Zhou, Yang, Zheng, Tongsen
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media S.A 09.12.2021
Témata:	advanced hepatocellular carcinoma immune-related criteria immunotherapy Oncology PD-1 inhibitor traditional evaluation criteria advanced hepatocellular carcinoma immune-related criteria traditional evaluation criteria PD-1 inhibitor immunotherapy
ISSN:	2234-943X, 2234-943X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!